PhD Cum Laude- Dr. ZHU Changbin

We are proud to announce that Dr. ZHU Changbin has been awarded the PhD degree with distinction Cum Laude based on his dissertation.

Research topic: On the Immune Regulation of Glioma Angiogenesis

Promotors: Prof. Dr. J.M. Kros

Dr. Changbin Zhu has successfully defended his PhD Dissertation on Tuesday, May 16, 2017 at Erasmus Medical Center.  

Dr. Changbin Zhu and his colleagues and friends 

Changbin Zhu was born in Shanghai, China on the date of 23rd, June, 1989. In 2007, after graduating his high school study from Shanghai Da Tong high school, one of the key point high schools in Shanghai, he started his medical education (8 year program) in Shanghai Jiao Tong University School of Medicine (SJTUSM). In 2009, he began his first research program on CCR5 in gastric and colorectal carcinoma under the supervision of Prof. Feng Chen and Prof. Jun Mei in SJTUSM. In 2010, this project was nominated as the Top 100 innovation projects for undergraduates in Shanghai. At the same time, he started his lab experience in Prof. Jianhua Wang’s lab working on Chemokine receptor CXCR7 in prostate cancers. This year also witnessed him donating hematopoietic stem cells to the patient with leukemia and being one of the volunteers in 2010 EXPO, Shanghai. Mainly due to his contribution to the patient, he was awarded “The excellent volunteer in the year of 2010”. In 2011, he was selected by the University of Michigan as the only exchange student doing lab internship. In the year of 2012, after clinical rotation in Shanghai Ruijin Hospital and Shanghai Xinhua hospital,under the financial support of China Scholarship Council (CSC), the 4 years’ Ph. D. program in Erasmus Medical Center, Rotterdam, the Netherlands started.

In the first two years, he followed the Master of Science molecular medicine program, and successfully got the M.Sc. degree in the September, 2014. From the year of 2013, he started his Ph.D. project on the immune systems and glioma angiogenesis under the guidance of Prof. Johan.M.Kros, Dr. Caroline Cheng and Dr. Dana Mustafa. In this project, he proposed and proved the pro-tumoral, pro-angiogenic and anti-inflammatory functions of novel protein CECR1 in the context of glioblastoma, one of the most aggressive brain tumors with dismal prognosis. His work is the first of our knowledge pointing the function of this novel molecule in oncology filed. This may bring new direction and approach to find new therapeutic way treating this rapid progression disease. From September, 2016, he came back to Shanghai continuing his medical training and would be specialized in pediatric neurosurgery under the guidance of Prof. Jie Ma in the Department of Pediatric neurosurgery, Shanghai Xinhua hospital. On 16th May, he was awarded the Ph.D degree with distinction cum laude based on his dissertation.